{"database": "press", "table": "releases", "rows": [["https://lipinski.house.gov/index.cfm?sectionid=91&itemid=3128", "Lipinski Successful in Effort to Reduce Regulations and Improve University Research Opportunities", "2016-11-28", "2016", "2016-11", "Democrat", "House", "IL", "Daniel Lipinski", "L000563", "lipinski.house.gov", null, null, "legacy", "Provisions based on Congressman Dan Lipinski\u2019s (IL-3) legislation, the University Regulation Streamlining and Harmonization Act, HR 5583, have been included in the broader health research and funding bill, the 21st Century Cures Act.\u00a0 Lipinski\u2019s bill, developed on recommendations from a National Academies report, would reduce the time and resources spent by researchers and universities in complying with excessive, duplicative, and inefficient federal regulations.\r\n\r\n\t\u201cThe federal government plays a leading role in funding research that keeps our nation on the forefront of science,\u201d Rep. Lipinski stated.\u00a0 \u201cUnfortunately, this funding comes with some unnecessary regulatory burdens.\u00a0 As a political science grad student and professor, I had my own experiences with federal research regulations, and now as a member of the Science Committee, I hear from former colleagues and leading researchers across the country about the excessive regulations, reporting, and monitoring they must deal with.\u00a0 While some of this is important to oversee the use of taxpayer dollars, increasingly these requirements take up an inordinate amount of researchers\u2019 time that could otherwise be devoted to cutting-edge research.\u201d\r\n\r\n\tThe 21st Century Cures Act, which the House is expected to consider this week, includes language parallel to Lipinski\u2019s bill establishing the Research Policy Board, a new advisory board at the Office of Management and Budget comprised of 10 Federal members and up to 12 representatives of academic research institutions, and other private, non-profit research groups.\u00a0 This advisory board will provide information on the effects of regulations on federal research requirements, including analysis of regulations and policy; identifying adverse consequences of policies and recommendations to improve them; conducting ongoing assessments of regulatory burdens, establishing metrics to measure them, and identifying process and policy improvements.\u00a0 The board must submit a report containing its initial formal recommendations within two years of enactment.\u00a0 The 21st Century CURES Act also includes language to prevent redundant grant monitoring and reporting, similar to Lipinski\u2019s bill.\r\n\r\n\t\u201cI\u2019m pleased that this important Research Policy Board language has been included in the CURES Act,\u201d said Lipinski.\u00a0 \u201cThis legislation will lead to more resources for finding treatments for cancer and other deadly and life-altering diseases, and I\u2019m glad to support its progress through Congress.\u00a0 Reducing researchers\u2019 regulatory burdens while also increasing funding for the National Institutes of Health and other health research will be a win-win for the research community.\u201d", 1, "2026-03-30T12:14:52Z", "2026-03-30T12:14:52Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://lipinski.house.gov/index.cfm?sectionid=91&itemid=3128"], "units": {}, "query_ms": 0.9866128675639629, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}